D J van Leeuwen - JoVE Visualize

Showing results (11-20 of 37) with videos related to

Pageof 4

Sort By:

Genes and Immunity|February 24, 2001

Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infectionL J Yee, J Tang, J Herrera, et al.

Annales De Chirurgie|January 1, 1991

Does additive radiotherapy after hilar resection improve survival of cholangiocarcinoma? An analysis in sixty-four patientsP C Verbeek, D J Van Leeuwen, M N Van Der Heyde, et al.

Seminars in Liver Disease|May 1, 1990

Technical considerations for the management of primary cholangiocarcinoma of the porta hepatisN J Lygidakis, M N Van der Heyde, P C Verbeek, et al.

Hepato-Gastroenterology|October 1, 1988

Early postoperative complications after (sub)total pancreatoduodenectomy: the AMC experienceG J Montagne, N J Lygidakis, M N van der Heyde, et al.

Gut|March 20, 1998

Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head regionM J Bruno, E B Haverkort, G P Tijssen, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1994

Role of antibiotics in the treatment and prevention of acute and recurrent cholangitisS J van den Hazel, P Speelman, G N Tytgat, et al.

Hepatology (Baltimore, Md.)|March 7, 2001

Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infectionL J Yee, J Tang, A W Gibson, et al.

The Netherlands Journal of Medicine|December 2, 2016

Peritoneal dialysis underscores its merits in portal hypertensionrelated and nephrogenic ascitesC W H de Fijter, V Leijdekkers, D J van Leeuwen, et al.

BMC Infectious Diseases|August 24, 2001

Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillanceL J Yee, H L Weiss, R G Langner, et al.

Annals of Internal Medicine|September 15, 1996

Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trialS J van den Hazel, P Speelman, J Dankert, et al.

Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:

Pageof 4

Genes and Immunity|February 24, 2001

Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infectionL J Yee, J Tang, J Herrera, et al.

Annales De Chirurgie|January 1, 1991

Does additive radiotherapy after hilar resection improve survival of cholangiocarcinoma? An analysis in sixty-four patientsP C Verbeek, D J Van Leeuwen, M N Van Der Heyde, et al.

Seminars in Liver Disease|May 1, 1990

Technical considerations for the management of primary cholangiocarcinoma of the porta hepatisN J Lygidakis, M N Van der Heyde, P C Verbeek, et al.

Hepato-Gastroenterology|October 1, 1988

Early postoperative complications after (sub)total pancreatoduodenectomy: the AMC experienceG J Montagne, N J Lygidakis, M N van der Heyde, et al.

Gut|March 20, 1998

Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head regionM J Bruno, E B Haverkort, G P Tijssen, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1994

Role of antibiotics in the treatment and prevention of acute and recurrent cholangitisS J van den Hazel, P Speelman, G N Tytgat, et al.

Hepatology (Baltimore, Md.)|March 7, 2001

Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infectionL J Yee, J Tang, A W Gibson, et al.

The Netherlands Journal of Medicine|December 2, 2016

Peritoneal dialysis underscores its merits in portal hypertensionrelated and nephrogenic ascitesC W H de Fijter, V Leijdekkers, D J van Leeuwen, et al.

BMC Infectious Diseases|August 24, 2001

Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillanceL J Yee, H L Weiss, R G Langner, et al.

Annals of Internal Medicine|September 15, 1996

Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trialS J van den Hazel, P Speelman, J Dankert, et al.

Pageof 4